Also, TMEM98 may confer chemoresistance of hepatocellular carcinoma through activation of the AKT pathway and deactivation of p53, suggesting its novel molecular target potential associated with intrinsic and acquired chemoresistance of hepatocellular carcinoma [26]. This evidence concerns the gene TP53 and hepatocellular carcinoma.